[go: up one dir, main page]

AU2001260834A1 - The treatment of herpes - Google Patents

The treatment of herpes

Info

Publication number
AU2001260834A1
AU2001260834A1 AU2001260834A AU6083401A AU2001260834A1 AU 2001260834 A1 AU2001260834 A1 AU 2001260834A1 AU 2001260834 A AU2001260834 A AU 2001260834A AU 6083401 A AU6083401 A AU 6083401A AU 2001260834 A1 AU2001260834 A1 AU 2001260834A1
Authority
AU
Australia
Prior art keywords
herpes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260834A
Inventor
Dianne Cadwallader
Craig Leonard Heatley
Timothy David Meakin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meracol Corp Ltd
Original Assignee
Meracol Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meracol Corp Ltd filed Critical Meracol Corp Ltd
Publication of AU2001260834A1 publication Critical patent/AU2001260834A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001260834A 2000-05-12 2001-05-11 The treatment of herpes Abandoned AU2001260834A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ504526 2000-05-12
NZ504526A NZ504526A (en) 2000-05-12 2000-05-12 Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
PCT/NZ2001/000086 WO2001085164A1 (en) 2000-05-12 2001-05-11 The treatment of herpes

Publications (1)

Publication Number Publication Date
AU2001260834A1 true AU2001260834A1 (en) 2001-11-20

Family

ID=19927882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260834A Abandoned AU2001260834A1 (en) 2000-05-12 2001-05-11 The treatment of herpes

Country Status (3)

Country Link
AU (1) AU2001260834A1 (en)
NZ (1) NZ504526A (en)
WO (1) WO2001085164A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ533370A (en) 2004-06-03 2006-11-30 Meracol Corp Ltd Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
EP2543364A1 (en) 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2589378A1 (en) 2010-10-14 2013-05-08 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2441441A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi A sieving method for cetyl myristate and/or cetyl palmitate
EP2441446A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
EP2471385A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471514A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations
EP2471384A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Suspension formulations of cetyl myristate and/or cetyl palmitate
EP2471387A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471386A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471528A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi A preparation method for suspension of cetyl myristate and/or cetyl palmitate
ES2538079T3 (en) 2011-05-23 2015-06-17 Deva Holding Anonim Sirketi Particle size distribution of cetyl myristate and / or cetyl palmitate
EP2526931B1 (en) 2011-05-23 2014-12-17 Deva Holding Anonim Sirketi Wet granulation methods of cetyl myristate and/or cetyl palmitate
WO2025151037A1 (en) * 2024-01-11 2025-07-17 Stir Pharma Limited Therapeutic methods and related compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
DE4308282C2 (en) * 1993-03-16 1994-12-22 Beiersdorf Ag Galenic matrices preferably in the form of microspheres
DE19819273A1 (en) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmaceutical ciclosporin formulation with improved biopharmaceutical properties, increased physical quality and stability as well as processes for its manufacture
EP1080226A4 (en) * 1998-05-21 2004-04-21 Isis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF OLIGONUCLEOTIDES
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
CA2369594A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same

Also Published As

Publication number Publication date
NZ504526A (en) 2003-05-30
WO2001085164A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2002327620A1 (en) Defibrillators
AU2001252135A1 (en) Therapeutic agents
AU2001245965A1 (en) Large body stretcher
AU5089400A (en) Arthritis treatment
AU5547000A (en) Novel treatment
AU2001260834A1 (en) The treatment of herpes
AU2002231206A1 (en) Treatment of depression
AU2001226910A1 (en) Electrolytic treatment
AU2002319650A1 (en) Defibrillators
AU2001236929A1 (en) Surface treatment
AU4556800A (en) Novel treatment
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001257325A1 (en) Cancer treatment
AU2002335667A1 (en) Modified reoviral therapy
AU2001273903A1 (en) Therapeutic agents
AU2001261324A1 (en) Psoriasis treatment
AU3714800A (en) Hiv therapy
AU4456800A (en) Human hac3
AU2001292897A1 (en) Novel therapy
AU2001289127A1 (en) Tumor treatment
AU2001253560A1 (en) Methods of treatment
AU2001257168A1 (en) Cancer treatment
AU5524399A (en) Inorgasmia treatment